Quantifying the impact of clinical coding in chronic kidney disease on risk of death and COVID-19 death
PLOS One · 2025
DOI: 10.1371/journal.pone.0333881 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Stuart Stewart und 5 weiteren Autor:innen. Beteiligte Einrichtung: Donal O'Donoghue Renal Research Centre, Research & Innovation, Northern Care Alliance NHS Foundation Trust, Salford, England, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, Renal Insufficiency, Chronic, Clinical Coding. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kidney Research UK.
Abstract (Originalsprache)
Background
Patients with biochemical evidence of chronic kidney disease (CKD) without a diagnostic code (uncoded CKD) in primary care are at increased risk of death, acute kidney injury (AKI), and unplanned hospital care. Uncoded CKD is highly prevalent and there is no data to evaluate whether patients with uncoded CKD were at an increased risk of COVID-19 death. Aim: to assess whether patients with uncoded CKD stages 3–5 were at increased risk of death and COVID-19 deaths.
Methods
Descriptive and inferential analyses to measure adjusted hazard of death, and COVID-19 death in patients with CKD stages 3–5 from 2.85 million primary care patients in Greater Manchester, England. Sensitivity analyses using propensity score matching and competing risk regression.
Results
Coded CKD stages 3 and 4 (versus uncoded) were associated with significantly lower adjusted hazards of death (HR 0.81, CIs 0.77–0.86, p=
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Donal O'Donoghue Renal Research Centre, Research & Innovation, Northern Care Alliance NHS Foundation Trust, Salford, England, United Kingdom.
- Centre for Primary Care & Health Services Research, University of Manchester, Manchester, England, United Kingdom.
- Division of Cardiovascular Sciences, University of Manchester, Manchester, England, United Kingdom.
- National Institute for Health and Care Research (NIHR) Greater Manchester Patient Safety Research Collaboration (GM PSRC), Manchester, England, United Kingdom.
- National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, University of Manchester, England, United Kingdom.
ORCID-Profile: Stuart Stewart
Förderung
- Kidney Research UK
Zitieren
APA
Stewart, S., Kalra, P. A., Kontopantelis, E., Blakeman, T., Tilston, G., & Sinha, S. (2025). Quantifying the impact of clinical coding in chronic kidney disease on risk of death and COVID-19 death. PLOS One. https://doi.org/10.1371/journal.pone.0333881
Vancouver
Stewart S, Kalra PA, Kontopantelis E, Blakeman T, Tilston G, Sinha S. Quantifying the impact of clinical coding in chronic kidney disease on risk of death and COVID-19 death. PLOS One. 2025. doi:10.1371/journal.pone.0333881
BibTeX
@article{Stewart2025,
author = {Stewart, Stuart and Kalra, Philip A and Kontopantelis, Evangelos and Blakeman, Tom and Tilston, George and Sinha, Smeeta},
title = {Quantifying the impact of clinical coding in chronic kidney disease on risk of death and COVID-19 death},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0333881}
}
EUVIMED